Skip to main content

Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.

Publication ,  Journal Article
Blumenthal, KG; Alvarez-Arango, S; Fu, X; Kroshinsky, D; Choi, H; Phillips, E; Zhou, L
Published in: JAMA Dermatol
December 1, 2022

Duke Scholars

Published In

JAMA Dermatol

DOI

EISSN

2168-6084

Publication Date

December 1, 2022

Volume

158

Issue

12

Start / End Page

1449 / 1453

Location

United States

Related Subject Headings

  • Vancomycin
  • Risk Factors
  • Humans
  • Eosinophilia
  • Drug Hypersensitivity Syndrome
  • Anti-Bacterial Agents
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blumenthal, K. G., Alvarez-Arango, S., Fu, X., Kroshinsky, D., Choi, H., Phillips, E., & Zhou, L. (2022). Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol, 158(12), 1449–1453. https://doi.org/10.1001/jamadermatol.2022.3541
Blumenthal, Kimberly G., Santiago Alvarez-Arango, Xiaoqing Fu, Daniela Kroshinsky, Hyon Choi, Elizabeth Phillips, and Li Zhou. “Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.JAMA Dermatol 158, no. 12 (December 1, 2022): 1449–53. https://doi.org/10.1001/jamadermatol.2022.3541.
Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, et al. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol. 2022 Dec 1;158(12):1449–53.
Blumenthal, Kimberly G., et al. “Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.JAMA Dermatol, vol. 158, no. 12, Dec. 2022, pp. 1449–53. Pubmed, doi:10.1001/jamadermatol.2022.3541.
Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, Zhou L. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol. 2022 Dec 1;158(12):1449–1453.

Published In

JAMA Dermatol

DOI

EISSN

2168-6084

Publication Date

December 1, 2022

Volume

158

Issue

12

Start / End Page

1449 / 1453

Location

United States

Related Subject Headings

  • Vancomycin
  • Risk Factors
  • Humans
  • Eosinophilia
  • Drug Hypersensitivity Syndrome
  • Anti-Bacterial Agents
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences